Per May 2026 Type C meeting, AXPAXLI NDA for wet AMD to be based on SOL-1 Week 52 efficacy and safety plus interim SOL-…
(“Sernova” or the “Company”) (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused…
Watch for follow-on moves from competitors and reactions from key channel partners in the coming quarters.
Une étude estime qu’un renforcement durable de la prévention pourrait éviter au minimum 340 000 cas de maladies chroniq…
Previously reserved for A-list clientele, Flik Swan’s elite training is now accessible across four complimentary enviro…
A new era in patient care brings advanced diagnostic imaging closer to home A new era in patient care brings advanced d…
(“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for …
Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated pat…
NeOnc Technologies Holdings (NASDAQ: NTHI) continues to build momentum as a neuro-oncology sector trailblazer For indus…
HCPro and ZHealth Publishing Partner to Advance Specialty Coding Excellence in Interventional Radiology and Cardiovascu…
Protein Industries Canada announces two projects focused on advancing Canada’s domestic food production capacity
